Aeterna Zentaris to Present at Upcoming Roth 25th Annual OC Growth Stock Conference

About this update from Cosciens Biopharma Inc.

[{"type":"text","content":"\n\n\n\n\n\nQUÉBEC CITY, March 13, 2013 /CNW Telbec/ - Aeterna Zentaris Inc.\n (NASDAQ: AEZS) (TSX: AEZ) (the \"Company\") today announced that its\n President and CEO, Juergen Engel, PhD, will be presenting a corporate\n overview at the Roth 25th Annual OC Growth Stock Conference on Tuesday, March 19, 2013, at 9:30\n am (Pacific), in Track 6: Salon 5-Pink of the Ritz Carlton hotel in\n Dana Point, California.\n\n\nA live webcast of this slide presentation will be available on Aeterna\n Zentaris' website at www.aezsinc.com, in the Newsroom section. A replay of the webcast will also be\n available on the Company's website for a period of 90 days.\n\n\nAbout Aeterna Zentaris \n\n\nAeterna Zentaris is an oncology and endocrinology drug development\n company currently investigating treatments for various unmet medical\n needs. The Company's pipeline encompasses compounds at all stages of\n development, from drug discovery through to marketed products. For more\n information please visit www.aezsinc.com.\n\nSOURCE: AETERNA ZENTARIS INC.\n\n\n Investor Relations Ginette Beaudet Vallières Investor Relations Coordinator (418) 652-8525 ext. [email protected] Media Relations Paul Burroughs Director of Communications (418) 652-8525 ext. [email protected] \n","length":1726,"tagName":"div"}]

More updates from Cosciens Biopharma Inc.